Correlation Between Kodiak Sciences and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kodiak Sciences and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kodiak Sciences and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kodiak Sciences and Effector Therapeutics, you can compare the effects of market volatilities on Kodiak Sciences and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kodiak Sciences with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kodiak Sciences and Effector Therapeutics.
Diversification Opportunities for Kodiak Sciences and Effector Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kodiak and Effector is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Kodiak Sciences and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Kodiak Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kodiak Sciences are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Kodiak Sciences i.e., Kodiak Sciences and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Kodiak Sciences and Effector Therapeutics
Considering the 90-day investment horizon Kodiak Sciences is expected to generate 0.67 times more return on investment than Effector Therapeutics. However, Kodiak Sciences is 1.5 times less risky than Effector Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 726.00 in Kodiak Sciences on August 24, 2024 and sell it today you would lose (107.00) from holding Kodiak Sciences or give up 14.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 80.04% |
| Values | Daily Returns |
Kodiak Sciences vs. Effector Therapeutics
Performance |
| Timeline |
| Kodiak Sciences |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kodiak Sciences and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kodiak Sciences and Effector Therapeutics
The main advantage of trading using opposite Kodiak Sciences and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kodiak Sciences position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Kodiak Sciences vs. Reviva Pharmaceuticals Holdings | Kodiak Sciences vs. Eyenovia | Kodiak Sciences vs. Cognition Therapeutics | Kodiak Sciences vs. Transcode Therapeutics |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |